Dublin, Oct. 19, 2017 -- The "Global Topical Drug Delivery Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024" report has been added to Research and Markets' offering.
Global topical drug delivery market is expected to reach USD 205.1 billion by 2024 from USD 101.7 billion in 2016, growing at a CAGR of 9.2% in the forecast period 2017 to 2024.
Scope of the Report
- On the basis of product type the market is segmented into transdermal drug delivery devices and topical drug delivery formulations.
- Topical drug delivery formulations are further segmented based on form into solid, semi-solid and liquid. The semi solid segment is further classified into ointments, creams, lotions, gels and pastes. The solid drugs segment is further segmented into powders and suppositories.
- The liquid drugs segment is further classified into solutions and suspensions. The transdermal drug delivery devices market segment is further segmented into patches and gels.
- The topical drug delivery market is segmented on the basis of indications into 4 types such as acne, anesthetics, psoriasis, dermatitis & atopic dermatitis, rosacea, onychomycosis, alopecia, actinic keratosis, and others.
- On the basis of end users the market is segmented into hospitals, home healthcare, clinics, diagnostic centers, and others.
Market Dynamics
Drivers
- Rising Cases of Acute and Chronic Disease
- Rising Aging Population
- Technological Advancements and Innovations
- Approval of New Drugs
- Better Opportunity in Pharmerging Markets
Restraints
- Regulatory Scenario and Pricing Pressure
Opportunity
- Emerging Market
- Rising Acceptance for Self-Administration of Drugs
Challenges
- Product Recall
- Penetration into the Smaller Markets
Galderma Pharma, S.A., dominated the topical drug delivery market accounting for a highest market share in 2016, followed by Bayer AG, and Valeant Pharmaceuticals.
- MedPharm, Janssen Pharmaceuticals, Inc. (A J&J Company)
- Crescita Therapeutics
- West Pharmaceutical Services
- Biofarmitalia s.r.l
- Pharmatek Laboratories, Inc.
- Stiefel Laboratories, Inc.
- Tapemark, Acrux Limited
- Nitto Denko Corporation
- Skinvisible Pharmaceuticals, Inc.
- Mylan Pharmaceuticals Inc.
- Pocono Coated Products LLC
- TheraSolve NV.
- Samyang Biopharmaceuticals Corporation
- Lohmann Therapie-Systeme AG
- Prosollus Pharmaceuticals
- Easton Pharmaceuticals Inc.
- Novosis AG
- Endo Pharmaceuticals Inc.
- Transdermal Technologies, Inc.
- Sheffield Pharmaceuticals, Inc.
- Solvay
Key Topics Covered:
1. Introduction
2. Market Segmentation
3. Market Overview
4. Premium Insights
5. Executive Summary
6. Global Topical Drug Delivery Market, by Type
7. Global Topical Drug Delivery Market, by Indication
8. Global Topical Drug Delivery Market, by Distribution Channel
9. Global Topical Drug Delivery Market, by End User
10. Global Topical Drug Delivery Market, by Geography
11. Global Topical Drug Delivery Market, Company Share
12. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/research/4pbdbl/global_topical
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Drug Delivery


Australia’s Modern Gold Rush: Hobby Prospectors Flock to Victoria’s Golden Triangle
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Starlink Plans Satellite Orbit Reconfiguration in 2026 to Boost Space Safety
Samsung Electronics Secures Annual U.S. Licence for China Chip Equipment Imports in 2026
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Google Accelerates AI Infrastructure With Ironwood TPU Expansion in 2026
Baidu Shares Surge as Company Plans Kunlunxin AI Chip Spin-Off and Hong Kong Listing
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 



